Latest News from: College of Veterinary Medicine, University of Illinois Urbana-Champaign

Filters close
Newswise: Promising Kidney Transplant Solution Taps Expertise of Dr. Jim Lowe
Released: 24-Oct-2023 5:05 PM EDT
Promising Kidney Transplant Solution Taps Expertise of Dr. Jim Lowe
College of Veterinary Medicine, University of Illinois Urbana-Champaign

In August, two U.S. surgical teams announced successful experimental kidney transplant from transgenic pigs into brain-dead human recipients. In both instances, the pig kidneys produced urine, carried out other functions of a kidney, and were not rejected by the body.

Newswise: Preliminary Data Support Novel Immunotherapy for Advanced Malignant Melanoma in Dogs
Released: 24-Oct-2023 5:05 PM EDT
Preliminary Data Support Novel Immunotherapy for Advanced Malignant Melanoma in Dogs
College of Veterinary Medicine, University of Illinois Urbana-Champaign

A clinical study of 11 dogs with advanced malignant melanoma demonstrated the efficacy, safety, and tolerability profile of cANK-101, a canine interleukin-12 anchored immunotherapy.

Newswise: Specific interneurons are important in aging-associated cognitive decline, study finds
Released: 28-Sep-2023 2:15 PM EDT
Specific interneurons are important in aging-associated cognitive decline, study finds
College of Veterinary Medicine, University of Illinois Urbana-Champaign

Normal aging is usually associated with a decline in memory, although it is unclear what factors play a role.

Released: 6-Sep-2023 10:55 AM EDT
T-Cells Infiltrate Brain, Cause Respiratory Distress in Condition Affecting the Immunocompromised
College of Veterinary Medicine, University of Illinois Urbana-Champaign

When an immunocompromised person’s system begins to recover and produce more white blood cells, it’s usually a good thing – unless they develop a potentially deadly inflammatory condition.

Released: 6-Sep-2023 10:25 AM EDT
Third NIH Grant Moves Novel Anti-Diarrheal Vaccine Forward
College of Veterinary Medicine, University of Illinois Urbana-Champaign

Dr. Weiping Zhang, professor in the Department of Pathobiology, was recently awarded a five-year, $5.6 million R01 grant from the National Institutes of Health (NIH) to optimize a promising vaccine against enterotoxigenic Escherichia coli (ETEC).


Showing results 1 – 5 of 5


close
0.0879